Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Abbott Park, Illinois 60064


To evaluate the safety, tolerability and pharmacokinetics of ABT-072 in healthy volunteers and its anti-viral activity in HCV infected subjects.

Study summary:

A blinded, randomized, placebo-controlled trial to study the safety, tolerability, antiviral activity and pharmacokinetic profiles of ABT-072 in healthy and HCV genotype-1 infected adults.


Inclusion Criteria: Criteria for Healthy Adults: - Informed consent has been obtained - Subject is in general good health - If female, then postmenopausal - If female, then not pregnant - If male, must be surgically sterile or both he and the partner must use birth control - Body Mass Index is 18 to 29, inclusive Criteria for HCV-infected Adults: - Infected with HCV for at least 6 months as shown by either detectable HCV RNA or reactive antibody, or liver biopsy with pathology indicative of HCV infection, or disclosure of a risk factor - Subject is infected with HCV genotype 1 with detectable HCV RNA of > 50,000 IU/mL Exclusion Criteria: Criteria for Healthy Adults: - If female, then pregnant or breast feeding - Positive HAV-IgM, HBs-Ag, HCV Ab or HIV Ab - Within 6 months of start of study, drug or alcohol abuse and use of nicotine products - Alcohol intake within 48 hours prior to study drug administration Criteria for HCV-infected Adults: - Need for prescription or over-the-counter medication - Child Pugh score > 5 or clinical evidence of cirrhosis - No other cause for liver disease other than HCV infection - ALT or AST > 4 x ULN - Creatinine > ULN - Clinically significant abnormal ECG - HCV RNA levels above the level of assay quantification - TSH values outside normal range



Primary Contact:


Backup Contact:


Location Contact:

Abbott Park, Illinois 60064
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.